Skin Color Matching in Head and Neck Reconstructive Surgery
Part of paid clinical trials in Guilford, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07431099
- Status
- Recruiting
Conditions
- Head and Neck Cancer
- Head and Neck Trauma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- RECELL® Autologous Cell Harvesting Device — DEVICERECELL Autologous Skin Cell Suspension (ASCS) will be used for color match and healing.
Study Details
This study will examine whether cutaneous reconstruction with RECELL® atop de-epithelialized tissue provides better skin color matching than standard grafting methods. The goal is to compare color match, healing, and patient satisfaction across three reconstruction techniques. Color matching will be assessed using colorimeter-based ΔE00 measurements at set postoperative intervals. All patients will receive the same intervention.
Key Dates
- Start date
- May 20, 2026
- Status verified
- May 2026
- Primary completion
- Sep 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Participants with head and neck cutaneous defect needing skin graftingParticipants with cutaneous defects of the head and neck requiring skin grafting will have their defect split into three sections and closed with one of the following: (1) split-thickness skin graft (STSG), (2) de-epithelialized tissue alone, or (3) de-epithelialized tissue with RECELL® ASCS. All participants will receive the same intervention and will serve as their own controls. STSG and de-epithelialized tissue alone are each currently used standards of care.
Primary Outcome Measure
Color match at the reconstruction site [ Time Frame: Postoperative assessments at Day 14 and months 1, 3, and 6 ]
Central Contacts
- Stanley Kusaka, BS971-325-8502
- Suresh Mohan, MD203-260-4622
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Shoreline Surgery Center | Guilford | Connecticut | 06437 | |
| Yale Milford Otolaryngology Clinic | Milford | Connecticut | 06460 | |
| Yale New Haven Hospital | New Haven | Connecticut | 06520 |
Find similar trials in Guilford, CT
By condition
Related Studies
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsPHASE2 · Recruiting · Daiichi Sankyo · Duarte, California
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPHASE1 · Recruiting · Pfizer · Duarte, California
- Identification and Characterization of Novel Proteins and Genes in Head and Neck CancerRecruiting · Stanford University · Stanford, California